Clearside Biomedical Inc (CLSD)
1.28
-0.03
(-2.29%)
USD |
NASDAQ |
May 06, 16:00
1.28
0.00 (0.00%)
After-Hours: 19:43
Clearside Biomedical Cash from Financing (Quarterly): -0.257M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.257M |
| September 30, 2023 | 0.317M |
| June 30, 2023 | 0.022M |
| March 31, 2023 | 0.332M |
| December 31, 2022 | 0.575M |
| September 30, 2022 | 30.69M |
| June 30, 2022 | 0.004M |
| March 31, 2022 | 0.065M |
| December 31, 2021 | 0.165M |
| September 30, 2021 | 2.081M |
| June 30, 2021 | 7.117M |
| March 31, 2021 | 14.42M |
| December 31, 2020 | 6.884M |
| September 30, 2020 | 2.429M |
| June 30, 2020 | -2.639M |
| March 31, 2020 | 1.193M |
| December 31, 2019 | -1.645M |
| September 30, 2019 | 2.424M |
| Date | Value |
|---|---|
| June 30, 2019 | 1.288M |
| March 31, 2019 | 6.628M |
| December 31, 2018 | 0.02M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 2.741M |
| March 31, 2018 | 79.02M |
| December 31, 2017 | 0.069M |
| September 30, 2017 | 0.001M |
| June 30, 2017 | 0.159M |
| March 31, 2017 | 5.133M |
| December 31, 2016 | 33.48M |
| September 30, 2016 | 8.039M |
| June 30, 2016 | 44.88M |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 19.95M |
| September 30, 2015 | 0.006M |
| June 30, 2015 | 5.988M |
| March 31, 2015 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-2.639M
Minimum
Jun 2020
30.69M
Maximum
Sep 2022
3.445M
Average
0.575M
Median
Dec 2022
Cash from Financing (Quarterly) Benchmarks
| Cassava Sciences Inc | 1.143M |
| Heron Therapeutics Inc | 0.199M |
| Actinium Pharmaceuticals Inc | 14.77M |
| Karyopharm Therapeutics Inc | 0.264M |
| Ocular Therapeutix Inc | 108.17M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 0.495M |
| Cash from Investing (Quarterly) | -0.12M |
| Free Cash Flow | -19.91M |
| Free Cash Flow Per Share (Quarterly) | 0.006 |
| Free Cash Flow to Equity (Quarterly) | 0.375M |
| Free Cash Flow Yield | -25.17% |